Cabaletta Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Selling, General & Admin	19.24	14.84	13.82	12.46	7.01	1.73
Research & Development	55.42	39.3	32.49	21.38	11.67	4.47
Operating Expenses	74.66	54.14	46.31	33.83	18.68	6.19
Operating Income	-74.66	-54.14	-46.31	-33.83	-18.68	-6.19
Other Expense / Income	-6.99	-1.16	-0.02	-0.49	-1.74	6.01
Pretax Income	-67.68	-52.98	-46.29	-33.34	-16.94	-12.2
Net Income	-67.68	-52.98	-46.29	-33.34	-16.94	-12.2
Preferred Dividends	0	0	0	0	5.33	0
Net Income Common	-67.68	-52.98	-46.29	-33.34	-22.27	-12.2
Shares Outstanding (Basic)	43	29	28	24	24	2
Shares Outstanding (Diluted)	-	-	-	-	-	2
Shares Change	47.69%	2.41%	17.78%	0.09%	1253.67%	-
EPS (Basic)	-1.65	-1.81	-1.80	-1.44	-4.07	-6.87
EPS (Diluted)	-1.65	-1.81	-1.80	-1.44	-4.07	-6.87
Free Cash Flow	-54.24	-48.83	-35.28	-27.41	-16.74	-4.66
Free Cash Flow Per Share	-1.27	-1.68	-1.25	-1.14	-0.70	-2.63
EBITDA	-64.18	-49.29	-45.56	-32.99	-16.84	-12.2
Depreciation & Amortization	3.5	3.68	0.73	0.35	0.1	0
EBIT	-67.68	-52.98	-46.29	-33.34	-16.94	-12.2

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).